Related content

Pegylated interferon for recurrent hepatitis C in liver transplant recipients with renal failure: a prospective cohort study

By Mukherjee S.   Gilroy R.K.   McCashland T.M.   Schafer D.F.  

Transplantation Proceedings, Vol. 35, Iss. 4, 2003-06 ,pp. : 1478-1479

Elsevier

Access to resources Recommend Favorite

1,25-Dihydroxyvitamin D 3 inhibits dendritic cell differentiation and maturation in vitro

By Berer A.   Stockl J.   Majdic O.   Wagner T.   Kollars M.   Lechner K.   Geissler K.   Oehler L.  

Experimental Hematology, Vol. 28, Iss. 5, 2000-05 ,pp. : 575-583

Elsevier

Access to resources Recommend Favorite

Inhibition of costimulatory pathways for T-cell activation by 1,25-dihydroxyvitamin D 3

By Penna G.   Adorini L.  

Transplantation Proceedings, Vol. 33, Iss. 3, 2001-05 ,pp. : 2083-2084

Elsevier

Access to resources Recommend Favorite

The coming of age of 1,25-dihydroxyvitamin D 3 analogs as immunomodulatory agents

By Mathieu C.   Adorini L.  

Trends in Molecular Medicine, Vol. 8, Iss. 4, 2002-04 ,pp. : 174-179

Elsevier

Access to resources Recommend Favorite

Influence of anticalcineurinic therapy in plasma homocysteine levels of renal transplant recipients: a prospective study

By Laures A.S.   Gomez E.   Alvarez V.   Coto E.   Baltar J.   Alvarez-Grande J.  

Transplantation Proceedings, Vol. 35, Iss. 5, 2003-08 ,pp. : 1739-1741

Elsevier

Access to resources Recommend Favorite